Abstract:Hepatocellular carcinomas (HCCs) are tumors with a highly developed vascular architecture. HCC cells require access to blood vessels for growth and metastasis; therefore, the inhibition of angiogenesis represents a potential therapeutic target for HCC that may reduce the mortality and morbidity from HCC. Various attempts to develop an anti-angiogenic therapy have been made in past decades; however, modest results have been achieved in clinical trials and the challenge of HCC treatment remains. Single-chain antibodies (scFv) are characterized by low molecular weight, low immunogenicity, high penetration and a short half-life, and are easy to produce on a large scale by genetic engineering. Accordingly, an scFv against a specific angiogenic regulator, such as angiopoietin (Ang), may be a promising anti-angiogenic therapy for HCC. Our previous study indicated that an imbalanced expression of angiopoietin-2 (Ang-2) vs. angiopoietin-1 (Ang-1) in HCCs contributes to initiation of neovascularization and promotes the angiogenesis and progression of HCCs. Therefore, we suggest that specific Ang-2-targeting interventions may be valuable in the treatment of HCC via remodeling the neovascular network and changing the tumor microenvironment. In this study, a prokaryotic expression vector of Ang-2 was constructed and purified human Ang-2 protein was isolated. An scFv against human Ang-2 (scFv-Ang2) was identified and purified via phage display technology, and the effects of scFv-Ang2 in vitro and in vivo on HCC in nude mice were evaluated. The results show that scFv-Ang2 inhibits vascular endothelial growth factor (VEGF) and Ang-2 induces the proliferation, migration and tubule formation of human umbilical vein endothelial cells (HUVECs) in vitro. In the in vivo assay, statistical indices, including tumor weight and volume, metastases to lungs, CD31 expression and the microvessel density (MVD) count in the scFv-Ang2-treated group of mice were significantly lower than those in the control group (P<0.05). In conclusion, the successfully generated scFv-Ang2 showed significant inhibitory effects on the angiogenesis and tumor growth of human HCC in vitro and in vivo.

High Expression of Human Angiogenesis Inhibitor HIAF-1 in Insect Cells and Biological Activity

[Cloning and Antitumor Activity of Angiogenesis Inhibitor HIAF-1].

Expression and Activity Determination of Human Angiostatin (K1-3) in Culture Cells and Larvae of Silkworm.

Expression and Function of Hepatocyte Growth Factor Activator Inhibitor Type 1

Expression of Human Endostatin in Larvae of Silkworm (bombyx Mori) and in Vitro Activity Assays.

[Effect of HAI-1 Over-Expression on in Vitro Growth and Migration/motility of SW620 Cells].

Inhibitory Efficacy of Local Angiostatin Expression in Treatment of Human Hepatic Carcinoma Cells

Construction of Recombinant Adenovirus of hAIF-1 Gene and Its Effect on Proliferation and Migration of A549 Cells

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

[Human Angiogenin: Expression, Purification, Biological Assay].

Experimental study of extract of fungi of huaier on angiogenesis in vitro

Construction of the Recombinant Adenovirus RNA Interference Vector of Human Hypoxia-Inducible Transcription Factor-1Α Gene and Its Effect on Expression of HIF-1α Gene in Human Lung Adenocarcinoma Cells SPCA-1

293. Sustained Expression of Kringle 1 Domain of Human Hepatocyte Growth Factor (HGFK1) Effectively Inhibits Angiogenesis, Growth and Metastasis of Hepatocellular Carcinoma

Recombinant Hepatocyte Growth Factor Activator Inhibitor 1: Expression in Drosophila S2 Cells, Purification and Crystallization

Prokaryotic Expression, Purification and Activity Assay of Recombinant Vascular Endothelial Growth Factor.

Suppression Of Angiogenesis And Tumor Growth In Vitro And In Vivo Using An Anti-Angiopoietin-2 Single-Chain Antibody

Construction of Recombinant Adenovirus Encoding mIκBα and the Suppression of Angiogenesis in Vitro

Construction of Recombinant Vector Pegfp-Ang and Expression of Angiogenin Gene in HUVECs

[The Inhibition of VEGF Expression Induced by HIF-1alpha RNA Interference].

Recombinant expression of human IL-17F fusion protein in E.coli and the study on its biological activity in vitro

Novel bibenzyl compound Ae exhibits anti-agiogenic activity in HUVECs in vitro and zebrafish in vivo